semaglutide news november 28 2025 FDA Approves to Reduce Kidney Disease, Cardiovascular Death Risk in Adults With Type 2 Diabetes, Chronic Kidney Disease Are you eligible? Medicare's new

A phase 3 clinical study with a higher dosage of daily 25 and 50 mg of oral semaglutide is about to be initiated, in the hope of obtaining promising data for both body weight reduction and cardiovascular benefits [34,37]

6 weeks: 3 vials use ~6 mL total

Patients who value provider messaging and care coaching as part of a weight management program, not just prescription access

Leslie Gammon, 54, an office manager from Wendell, North Carolina, said she turned to a telehealth company called Amble Health for a weight loss drug prescription

You know that a very high percentage of the dose you administer is reaching systemic circulation and becoming available to interact with its target receptors

In STEP 4, the extension of the STEP 1 trial of semaglutide, placebo patients regained around half their prior weight after a year